Making menopause more manageable
Menopause can cause symptoms that affect sleep, mood, and quality of life. Menopause is defined as no menstrual bleeding for a year. On average, women in the U.S. reach this point at age 51.
Natural menopause occurs over a period of years triggering symptoms typically ranging from mild to moderate. In contrast, women with breast cancer often enter menopause abruptly or early due to cancer treatment. Their symptoms are often more severe and last longer. Vasomotor symptoms include hot flashes and night sweats that disrupt sleep and result in fatigue, brain fog, and mood changes.
In Tuesday’s presentation, researchers reported that 70% of breast cancer survivors who are in menopause experience genitourinary syndrome of menopause. Genitourinary symptoms include vaginal dryness, painful sex, low sex drive, thinning or drying of the vaginal walls, and urinary symptoms. And the impact is not only physical – these symptoms also affect body image, relationships, and sexual health.
Although hormone replacement therapy is effective at managing symptoms of menopause, it has been mired in controversy since the early 1990s when doctors mostly stopped prescribing it. The studies that raised alarms in the past tested an older drug different from what is prescribed today.
The FDA’s recent announcement that it will remove the black box warnings on all hormone therapies reflects newer research about the safety of hormone therapy, but confusion remains.
By having open conversations with your healthcare team about options that are right for your situation, you can take an important step to regaining control of your menopausal symptoms.
Treatment options for menopausal symptoms include:
- Medications to relieve vasomotor symptoms like hot flashes and night sweats are newer options for people diagnosed with breast cancer.
- Vaginal moisturizers and lubricants may help with vaginal dryness. Moisturizers can be used daily while lubricants are used as needed. While these products bring some relief, they do not always work well enough.
- Menopausal hormone therapy, sometimes referred to as HRT, is a therapy that restores hormones to the whole body (systemic therapy). It is effective for preventing bone loss and can restore vaginal cells, potentially improving dryness and sexual side effects. But systemic hormone therapy is not recommended for women with breast cancer by the American Society of Clinical Oncologists. Confused by mixed messages? Make a plan to discuss your options with your healthcare provider.
- Low-dose vaginal estrogen and vaginal dehydroepiandrosterone (DHEA) are forms of estrogen therapy that are applied only to the vaginal tissue. Major health organizations have endorsed the use of low-dose vaginal estrogen even in women with a history of early-stage breast cancer, but many doctors are still wary of offering these options. It is important to discuss the safety data as it relates to your health situation and balance your quality of life considerations. DHEA has not been studied as much in women with breast cancer but may be a good option for people who are nervous about vaginal estrogen. Research is ongoing in women with metastatic breast cancer on ovarian suppression.